Literature DB >> 29569974

Efficacy of ibrutinib as first-line treatment of tumoral Bing-Neel syndrome.

Laurys Boudin1, Matthieu Patient1,2, Emilie Roméo1, Jean-Sébastien Bladé1, Jean-Pierre de Jauréguiberry1,2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2018        PMID： 29569974     DOI： 10.1080/10428194.2018.1441409

Source DB:  PubMed          Journal:  Leuk Lymphoma        ISSN： 1026-8022


× No keyword cloud information.
  5 in total

1.  Standard Dose of Ibrutinib is Effective in the Treatment of Bing-Neel Syndrome.

Authors:  Mark Plander; Tamás Szendrei; Árpád Vadvári; János Iványi
Journal:  Pathol Oncol Res       Date:  2018-10-25       Impact factor: 3.201

2.  Treatment of Bing-Neel syndrome with first line sequential chemoimmunotherapy: A case report.

Authors:  Maria Gavriatopoulou; Ioannis Ntanasis-Stathopoulos; Lia-Angela Moulopoulos; Alexandros Manaios; Despina Fotiou; Evangelos Eleutherakis-Papaiakovou; Magdalini Migkou; Charis Bourgioti; Evangelos Terpos; Efstathios Kastritis; Meletios-Athanasios Dimopoulos
Journal:  Medicine (Baltimore)       Date:  2019-11       Impact factor: 1.817

3.  Bing-Neel Syndrome: Real-Life Experience in Personalized Diagnostic Approach and Treatment.

Authors:  Dimitrios Kotsos; Sofia Chatzileontiadou; Athanasia Apsemidou; Anna Xanthopoulou; Aikaterini Rapi; Christina Frouzaki; Evdoxia Hatjiharissi
Journal:  Front Oncol       Date:  2022-06-29       Impact factor: 5.738

4.  Bing-Neel Syndrome, a Rare Presentation of Waldenström Macroglobulinemia-A Multicenter Report by the Polish Lymphoma Research Group.

Authors:  Joanna Drozd-Sokołowska; Anna Waszczuk-Gajda; Magdalena Witkowska; Elżbieta Sienkiewicz; Anna Kopińska; Agnieszka Kołkowska-Leśniak; Joanna Barankiewicz; Monika Długosz-Danecka; Piotr Smolewski; Grzegorz Helbig; Ewa Lech-Marańda; Wojciech Jurczak; Przemysław Biecek; Sebastian Giebel; Wiesław Wiktor-Jędrzejczak; Grzegorz Basak
Journal:  J Clin Med       Date:  2022-07-30       Impact factor: 4.964

5.  A Case of Bing-Neel Syndrome Successfully Treated with Ibrutinib.

Authors:  Alobeid Bachir; Daniel S O'Neil; Mark A Francescone; Karen Khan; Bachir Alobeid; Owen A O'Connor; Ahmed Sawas
Journal:  Case Rep Hematol       Date:  2018-08-28
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.